Browse by author
Lookup NU author(s): Therese Small
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Rationale: Bronchial thermoplasty (BT) is designed to reduce airway smooth muscle and improve asthma control. Objectives: This study was conducted to determine the safety and efficacy of this procedure in subjects with symptomatic, severe asthma. Methods: Adults who were symptomatic despite treatment with fluticasone or equivalent at more than 750 μg/day, a long-acting β2-agonist, and other medications, which could include 30 mg or less of oral prednisolone/day, were randomized to BT or to a control group. After treatment, subjects entered a 16-week steroid stable phase (Weeks 6-22), a 14-week steroid wean phase (Weeks 22-36), and a 16-week reduced steroid phase (Weeks 36-52). Measurements and Main Results: BT resulted in a transient worsening of asthma symptoms. Seven hospitalizations for respiratory symptoms occurred in 4 of 15 BT subjects during the treatment period. Five hospitalizations were within 3 days of treatment. Two subjects had segmental collapse involving the most recently treated lobe; one required bronchoscopy and aspiration of a mucus plug. There werenohospitalizations during this period in the17 control subjects. The rate of hospitalizations was similar in both groups in the post-treatment period. At 22 weeks, BT subjects had significant improvements versus control subjects in rescue medication use (-26.6 ± 40.1 vs. -1.5 ± 11.7 puffs/7 d, P < 0.05), prebronchodilator FEV 1% predicted (14.9 ± 17.4 vs. -0.94 ± 22.3%, P = 0.04), and Asthma Control Questionnaire scores (-1.04 ± 1.03 vs. -0.13 ± 1.00, P = 0.02). Improvements in rescue medication use and Asthma Control Questionnaire scores remained significantly different from those of controls at 52 weeks. Conclusions: BT is associated with a short-term increase in asthma-related morbidity. However, there is preliminary evidence of long-lasting improvement in asthma control. Clinical trial registered with www.clinicaltrials.gov (NCT 00214539).
Author(s): Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, Laviolette M, Berry M, Shaw D, Sheldon N, Miller J, Nair P, Goodwin S, Currie K, Chaudhuri R, Bicknell S, Livingston E, Lafferty J, Cardoso PG, Soares PRD, Higgins B, Small T, Foggo B, Prys-Picard C, Fletcher G, Shah P, Lim M, Meah S, Martel S, Boulet L-P, Morel L, Trepanier L
Publication type: Article
Publication status: Published
Journal: American Journal of Respiratory and Critical Care Medicine
Year: 2007
Volume: 176
Issue: 12
Pages: 1185-1191
ISSN (print): 1073-449X
ISSN (electronic): 1535-4970
Publisher: American Thoracic Society
URL: http://dx.doi.org/10.1164/rccm.200704-571OC
DOI: 10.1164/rccm.200704-571OC
PubMed id: 17901415
Altmetrics provided by Altmetric
